20
Chongqing Huapont Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BENDAMUSTINE HCL, with a corresponding US DMF Number 25524.
Remarkably, this DMF maintains an Active status since its submission on November 24, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 25, 2015, and payment made on September 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II